Indeed, it has been suggested that tumor growth was associated with accumulation of regulatory B cells (Breg) within TDLNs (52–54), which in turn could promote cancer cells recruitment via the production of anti-HSPA4 immunoglobulin and the activation of the CXCL12/CXCR4 pathway (55). The gene discussed is HSPA4; the disease is neoplasm.